一种树突性药物-药物结合体,用于组合治疗的自组合的低氧反应超分子纳米粒子
Tianlong Ling1, Xiaogang Huang2, Yu Xie3
1Department of Gastrointestinal Surgery, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200127, China. skyjjchen@sohu.com.
Journal of materials chemistry. B
|January 14, 2025
概括
这项研究引入了用于癌症治疗的新型低氧反应纳米粒子. 它结合了光热,光动力学和化疗,提高了对瘤的治疗疗效.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术纳米技术
- 癌症治疗 癌症治疗
背景情况:
- 缺氧是一种常见的瘤微环境特征,降低了癌症治疗的有效性,并促进了转移.
- 需要先进的纳米载体,能够应对缺氧条件并集成多种治疗方式.
- 现有的治疗方法与缺氧诱导的抗性和侵入性作斗争.
研究的目的:
- 开发一种对缺氧反应的超分子纳米粒子,用于协同光热疗法 (PTT),光动力疗法 (PDT) 和化疗 (CT).
- 为了克服瘤缺氧在癌症治疗中所带来的挑战.
- 创建一个多功能纳米平台,以提高治疗效果.
主要方法:
- 使用树突性药物-药物联合体 (IR806-Azo-CB4) 和阳离子支柱烯 (AWBpP6) 制造一个对缺氧反应的超分子纳米粒子 (SN@IR806-CB).
- 利用 π-π 堆叠,宿主-客人复杂化和水性相互作用进行纳米粒子组装.
- 在近红外 (NIR) 辐射下研究了PTT,PDT和CT协同效应.
主要成果:
- 在NIR照射下,SN@IR806-CB纳米粒子通过高热生成有效的PTT和通过单片氧 (1O2) 生产通过PDT.
- 通过PDT诱导的缺氧恶化被证明可以加速激活化疗药物 (CB) 的释放.
- 结合PTT-PDT-CT方法显示了对协同瘤切除的显著潜力.
结论:
- 开发的低氧反应性纳米粒子SN@IR806-CB为多模式癌症治疗提供了一个有前途的战略.
- 这种纳米平台有效地利用瘤缺氧来增强药物释放和治疗协同作用.
- 综合PTT-PDT-CT方法具有提高癌症治疗疗效的巨大潜力.
相关概念视频
Modified-Release Drug Delivery Systems: Stimuli-Activated
177
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also...
177
Modified-Release Drug Delivery Systems: Site-Targeted
164
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
164
Site-Targeted Drug Delivery Systems: Polymeric Carriers
160
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
160


